Antibody Engineering based on In situ Programmable Nucelic Acid Editing

Erdoğan M. (Executive), Özkul A.

H2020 Project, 2020 - 2022

• Project Type: H2020 Project
• Begin Date: January 2020
• End Date: April 2022